DrugsPRO / Library / Μεπιραπίμη

Library

Μεπιραπίμη

MEPIRAPIM is an indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA. MEPIRAPIM acts as a T-type calcium channel inhibitor and is only minimally active at the CB1 receptor.

Μεπιραπίμη molecular structure
Μεπιραπίμη molecular structure diagram from the DrugsPRO substance library.

Also known as: (4-methylpiperazin-1-yl)-(1-pentylindol-3-yl)methanone

Classification

  • Chemical: Cannabinoid
  • Chemical: Synthetic cannabinoid

Effects

  • Sedation
  • Anxiety
  • Paranoia
  • Euphoria
  • Dehydration

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Interactive library page More substances Sitemap index

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Get it on Google Play Download on the App Store

Mepirapim - Οδηγός ουσίας DrugsPRO

Mepirapim: MEPIRAPIM is an indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA. MEPIRAPIM acts as

Related pages